Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ovarian Cycle01:27

Ovarian Cycle

2.7K
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
2.7K
Infertility in Females01:28

Infertility in Females

3.5K
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...
3.5K
Infertility in Males01:23

Infertility in Males

428
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
428
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

138
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
138
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

4.4K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.4K
Teratogenicity01:07

Teratogenicity

3.7K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical potential of fluid-based biomarkers for recurrent implantation failure: a systematic review.

Frontiers in endocrinology·2026
Same author

Embryo Implantation: New Molecular Insights in Endometrial Receptivity, Trophoblast Invasion and Signalling-An Introduction.

Biomolecules·2026
Same author

Multi-Omics Reveals Early Pregnancy Placental Dysfunction Associated With Preterm and Term Preeclampsia.

MedComm·2026
Same author

Characterization of elevated levels of endometrial renin-angiotensin system components suggest a role in endometrial repair.

Frontiers in endocrinology·2026
Same author

The impact of cannabigerol exposure on human endometrial stromal cells decidualization.

Toxicology·2026
Same author

Myosin heavy chain 10 dysregulation in infertile endometrial epithelial cells impairs adhesive capacity.

Open biology·2026
Same journal

Accidental hypothermia.

Nature reviews. Disease primers·2026
Same journal

Accidental hypothermia.

Nature reviews. Disease primers·2026
Same journal

Primary aldosteronism.

Nature reviews. Disease primers·2026
Same journal

Primary aldosteronism.

Nature reviews. Disease primers·2026
Same journal

Buruli ulcer in Africa: between innovation and pragmatism.

Nature reviews. Disease primers·2026
Same journal

Author Correction: Atopic dermatitis.

Nature reviews. Disease primers·2026
See all related articles

Related Experiment Video

Updated: Nov 26, 2025

Multiplexed Fluorescent Immunohistochemical Staining of Four Endometrial Immune Cell Types in Recurrent Miscarriage
05:16

Multiplexed Fluorescent Immunohistochemical Staining of Four Endometrial Immune Cell Types in Recurrent Miscarriage

Published on: August 4, 2021

3.6K

Recurrent pregnancy loss.

Evdokia Dimitriadis1,2, Ellen Menkhorst3,4, Shigeru Saito5

  • 1Department of Obstetrics and Gynaecology, University of Melbourne, The Women's Hospital, Melbourne, Australia. eva.dimitriadis@unimelb.edu.au.

Nature Reviews. Disease Primers
|December 11, 2020
PubMed
Summary
This summary is machine-generated.

Recurrent pregnancy loss affects 2.5% of women. While prognosis is generally good, understanding causes like chromosomal errors and uterine defects is key for successful future pregnancies.

More Related Videos

Author Spotlight: Advancing Reproductive Immunology with a Protocol for the Quantitative Evaluation of Endometrial Immune Cells
07:46

Author Spotlight: Advancing Reproductive Immunology with a Protocol for the Quantitative Evaluation of Endometrial Immune Cells

Published on: October 13, 2023

1.6K
Mouse Model of Surgical Uterine Injury and Subsequent Pregnancy Outcomes
04:08

Mouse Model of Surgical Uterine Injury and Subsequent Pregnancy Outcomes

Published on: June 27, 2025

814

Related Experiment Videos

Last Updated: Nov 26, 2025

Multiplexed Fluorescent Immunohistochemical Staining of Four Endometrial Immune Cell Types in Recurrent Miscarriage
05:16

Multiplexed Fluorescent Immunohistochemical Staining of Four Endometrial Immune Cell Types in Recurrent Miscarriage

Published on: August 4, 2021

3.6K
Author Spotlight: Advancing Reproductive Immunology with a Protocol for the Quantitative Evaluation of Endometrial Immune Cells
07:46

Author Spotlight: Advancing Reproductive Immunology with a Protocol for the Quantitative Evaluation of Endometrial Immune Cells

Published on: October 13, 2023

1.6K
Mouse Model of Surgical Uterine Injury and Subsequent Pregnancy Outcomes
04:08

Mouse Model of Surgical Uterine Injury and Subsequent Pregnancy Outcomes

Published on: June 27, 2025

814

Area of Science:

  • Reproductive Medicine
  • Genetics
  • Immunology

Background:

  • Recurrent pregnancy loss (RPL) affects ~2.5% of women trying to conceive.
  • Defined as ≥2 pregnancy losses before 20-24 weeks gestation.
  • Diagnosis challenges exist due to lack of standardized definitions and understanding of pathogenesis.

Purpose of the Study:

  • To review the current understanding of recurrent pregnancy loss.
  • To discuss diagnostic challenges and prognostic factors.
  • To explore available treatments and future research directions.

Main Methods:

  • Literature review of studies on recurrent pregnancy loss.
  • Analysis of diagnostic criteria and treatment efficacy.
  • Synthesis of information on etiology and prognosis.

Main Results:

  • Prognosis for successful pregnancy is generally good, influenced by maternal age and prior losses.
  • Identified causes include chromosomal errors, uterine defects, autoimmune disorders, and endometrial dysfunction.
  • Treatment effectiveness is often controversial, necessitating targeted interventions.

Conclusions:

  • Accurate information and psychological support are crucial for couples experiencing RPL.
  • Further research is needed to elucidate pathogenesis and evaluate novel diagnostic tests and treatments.
  • Standardized definitions and robust clinical trials are essential for advancing RPL management.